title: GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'.
abstract: Allergic diseases represent a major health problem in Europe. They are increasing in prevalence, severity and costs. The Global Allergy and Asthma European Network (GA(2)LEN), a Sixth EU Framework Program for Research and Technological Development (FP6) Network of Excellence, was created in 2005 as a vehicle to ensure excellence in research bringing together research and clinical institutions to combat fragmentation in the European research area and to tackle allergy in its globality. The Global Allergy and Asthma European Network has benefited greatly from the voluntary efforts of researchers who are strongly committed to this model of pan-European collaboration. The network was organized in order to increase networking for scientific projects in allergy and asthma around Europe and to make GA(2)LEN the world leader in the field. Besides these activities, research has also been carried out and the first papers are being published. Achievements of the Global Allergy and Asthma European Network can be grouped as follows: (i) those for a durable infrastructure built up during the project phase, (ii) those which are project-related and based on these novel infrastructures, and (iii) the development and implementation of guidelines. The major achievements of GA(2)LEN are reported in this paper.
authors.affiliation: University Hospital and INSERM U780, Hôpital Arnaud de Villeneuve, Montpellier, France.
authors.forename: J
authors.initials: J
authors.lastname: Bousquet
authors.forename: P G
authors.initials: PG
authors.lastname: Burney
authors.forename: T
authors.initials: T
authors.lastname: Zuberbier
authors.forename: P V
authors.initials: PV
authors.lastname: Cauwenberge
authors.forename: C A
authors.initials: CA
authors.lastname: Akdis
authors.forename: C
authors.initials: C
authors.lastname: Bindslev-Jensen
authors.forename: S
authors.initials: S
authors.lastname: Bonini
authors.forename: W J
authors.initials: WJ
authors.lastname: Fokkens
authors.forename: F
authors.initials: F
authors.lastname: Kauffmann
authors.forename: M L
authors.initials: ML
authors.lastname: Kowalski
authors.forename: K
authors.initials: K
authors.lastname: Lodrup-Carlsen
authors.forename: J
authors.initials: J
authors.lastname: Mullol
authors.forename: E
authors.initials: E
authors.lastname: Nizankowska-Mogilnicka
authors.forename: N
authors.initials: N
authors.lastname: Papadopoulos
authors.forename: E
authors.initials: E
authors.lastname: Toskala
authors.forename: M
authors.initials: M
authors.lastname: Wickman
authors.forename: J
authors.initials: J
authors.lastname: Anto
authors.forename: N
authors.initials: N
authors.lastname: Auvergne
authors.forename: C
authors.initials: C
authors.lastname: Bachert
authors.forename: P J
authors.initials: PJ
authors.lastname: Bousquet
authors.forename: B
authors.initials: B
authors.lastname: Brunekreef
authors.forename: G W
authors.initials: GW
authors.lastname: Canonica
authors.forename: K H
authors.initials: KH
authors.lastname: Carlsen
authors.forename: M
authors.initials: M
authors.lastname: Gjomarkaj
authors.forename: T
authors.initials: T
authors.lastname: Haahtela
authors.forename: P
authors.initials: P
authors.lastname: Howarth
authors.forename: G
authors.initials: G
authors.lastname: Lenzen
authors.forename: J
authors.initials: J
authors.lastname: Lotvall
authors.forename: K
authors.initials: K
authors.lastname: Radon
authors.forename: J
authors.initials: J
authors.lastname: Ring
authors.forename: M
authors.initials: M
authors.lastname: Salapatas
authors.forename: H J
authors.initials: HJ
authors.lastname: Schünemann
authors.forename: A
authors.initials: A
authors.lastname: Szczecklik
authors.forename: A
authors.initials: A
authors.lastname: Todo-Bom
authors.forename: E
authors.initials: E
authors.lastname: Valovirta
authors.forename: E
authors.initials: E
authors.lastname: von Mutius
authors.forename: J P
authors.initials: JP
authors.lastname: Zock
mesh_terms: D000485:Allergens / Q000276:immunology; D001249:Asthma / Q000453:epidemiology* / Q000235:genetics / Q000276:immunology; D002986:Clinical Trials as Topic; D003299:Cooperative Behavior; D004781:Environmental Exposure; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000453:epidemiology* / Q000235:genetics / Q000276:immunology; D007391:International Cooperation / Q000331:legislation & jurisprudence*; D008297:Male; D016730:Program Development; D012737:Sex Factors
chemical_list: D000485:Allergens